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The ratio of observed-to-expected deaths is considered a measure of hospital quality and for this reason will soon become a basis
for payment. However, there are drivers of that metric more potent than quality: most important are medical documentation and
patient acuity. If hositals underdocument and therefore do not capture the full “expected mortality” they may be tempted to lower
theirobserved/expectedratiobyreducing“observedmortality”throughlimitingaccesstotheveryill.Underdocumentationoccurs
because hospitals do not recognize, and therefore cannot seek to conﬁrm, speciﬁc comorbidities conferring high mortality risk.
To help hospitals identify these comorbidities, this paper describes an easily implemented spread-sheet for evaluating comorbid
conditions associated, in any particular hospital, with each discharge. This method identiﬁes comorbidities that increase in
frequency as mortality risk increases within each diagnostic grouping. The method is inductive and therefore independent of
any particular risk-adjustment technique.
1.Introduction
Risk of death in a hospitalized patient—and therefore the
number of deaths expected in a hospital—is usually calcu-
lated using demographic and coded diagnostic and procedu-
ral information. A variety of private companies, trade orga-
nizations, and government agencies have developed mathe-
matical models for calculating expected mortality; most of
them employ roughly the same data set and use similar tech-
niques of logistic regression [1–6]. The ratio between actual
and expected deaths is widely considered to reﬂect quality of
care, and as hospital performance data circulate ever more
widely on the internet, this ratio has become a metric of
increasing prominence [7, 8].
Soon risk-adjusted mortality will be of importance also
to hospital revenue. Last year, the Center for Medicare
and Medicaid Services (CMS) announced plans to withhold
from each hospital a percentage of payments derived from
diagnosis-related groupings (DRGs). These funds will be
kept in a national pool and redistributed using indicators of
quality and patient satisfaction chosen by CMS. A hospital
may lose all of its withheld payments or receive well over
twice the amount withheld. Observed-to-expected mortality
in three DRGs is scheduled in 2014 to become one of the
factors determining the percentage returned [9].
As hospitals attempt to maximize payment, they will
take straightforward steps to increase compliance with those
processes identiﬁed by CMS as quality related. They will also
create initiatives to improve patient satisfaction. However,
it is more diﬃcult to conceive what speciﬁc measures a
hospital might employ to decrease observed-to-expected
mortality overall. With an important ﬁnancial stake but
no available strategy to protect that stake, hospitals will
approach observed-to-expected mortality with concern.
To patients as well as insurance companies, there is
undeniable appeal in a metric that purports to compare life-
savingprowessbetweenhospitals.Manywillwanttochoosea
hospitalbasedperhapslargelyonsuchametric.Itistherefore
important both to make certain that the metric is fairly
appliedandtounderstandthelimitsonourabilitytoidentify
institutions that prevent death.
1.1. Observed Deaths. Observed deaths, the numerator, are
usually an unavoidable result of end-stage or sudden and
overwhelming illness. These deaths, and not the relatively
few cases for which quality issues are determinative, mainly
populate the numerator of observed/expected mortality.
Because marginally preventable deaths are relatively uncom-
mon, numerator variations tend to be more responsive to
the acuity of a hospital’s patients than to the quality of its2 Computational and Mathematical Methods in Medicine
care. Every patient who dies increases numerator more than
denominator because expectation of death is never 100%.
The inevitable eﬀect of increasing acuity is therefore an
unwanted increase in the ratio. On the other hand, surviving
low-acuity patients always increase denominator more than
numerator because expectation of death is never 0%. The
result is a desirable decrease in the ratio.
Enhancing quality of care is of course the intended strat-
egy—improving observed/expected mortality by decreasing
the “observed” numerator selectively among those patients
whose survival is problematic but within reach. These are a
small minority of numerator cases, however, while lowering
institutional acuity broadly improves both numerator and
denominator. Lower acuity also decreases the number of
extremely long-stay patients, perhaps the most important
driverofanothercloselywatchedhospitalparameter,average
length of stay.
Avoidingveryillpatientsortransferringthembeforethey
die may be mathematically a more eﬀective way to decrease
mortality ratio and practically easier to implement than a
quality improvement eﬀort with no very clear focus. The
use of observed/expected mortality as a quality marker and
a reimbursement multiplier may, therefore, threaten to limit
hospital access for the very ill.
1.2. Expected Deaths. Not only institutional acuity but
also choice of risk adjustment paradigm inﬂuences the
denominator (“expected deaths”). Current methods of risk
adjustment have been shown to predict death with variable
accuracy and to disagree with each other substantially and
often [10–12].
Variability in these calculations of mortality risk arises
from the intrinsic diﬃculty in assessing severity of the prin-
cipal diagnosis itself, particularly using administrative data
that lack clinical detail. ICD-9 disease categories underlying
all risk adjustment capture subtle diﬀerences in etiology
but characterize severity less well, mainly by appending
comorbidities. Yet severity of the principal diagnosis is of the
ﬁrst importance in predicting death, and mortality is also
inﬂuenced by demographic and psychosocial factors, such
as access to care and treatment setting [13, 14]. Like disease
severity, the eﬀect of these factors is not well captured by
ICD-9.
Describing interactions among the intrinsic severity of
a principal diagnosis, psychosocial factors, and the large
number of possible comorbid conditions is the major
mathematical problem of risk adjustment. Opportunities are
many for excluding important variables and associations,
for under- and overﬁtting, and for model instability due
to variable colinearity. Inclusion of late-occurring, virtually
death-deﬁning diagnoses (asystole or cardiac arrest, e.g.,)
as predictors of death can artiﬁcially enhance the apparent
predictive power of risk adjustment models.
Animportantadditionalreasonforpoormodelprecision
is that documentation practices vary among hospitals. Those
with“sicker”patientshavebeenshowntobeoftenovercoded
[15]. Equally problematic is the observation that patients
who die tend as a group to be undercoded [16]. Whether
extracted during record review or sent to databases auto-
matically after coding, comorbid diagnoses are derived from
documentation in the medical record; it is their assigned
weights that largely determine expected risk of death in most
adjustment methodologies. Both over-and undercoding can
lead, therefore, to inaccurate risk assessment. Perhaps the
most important kind of overcoding is failure to distinguish
between complications and comorbidities [17]. CMS now
requires hospitals to designate comorbidities that were
present on admission (POA); however, compliance with this
requirement is not complete even when a POA determina-
tion is easily made. The result can be risk adjustment that
“charges” to the patient medical conditions actually caused
by the hospital, resulting in overestimation of expected
mortality [18, 19].
Undercoding arises from a failure to document or code
thosefewcomorbiditieswithineachdiagnosticgroupingthat
specify a substantially increased risk of death. Within any
risk-adjustment model, each comorbidity has a coeﬃcient
relating that comorbidity to the likelihood of death only
in a particular DRG (or other grouping) and often only
in the company of other particular comorbidities, but that
coeﬃcient is rarely large. Clinicians and coders cannot easily
pick out these large-coeﬃcient comorbidities because there
are too many combinations of risk level, grouping, and
comorbidity to keep track of. In addition, the majority of
institutions purchase risk adjustment services that are pro-
prietary; the general logic of their method is available, but
speciﬁc determinants of risk are usually not.
A hospital, therefore, may not easily identify character-
istic comorbidities that contribute heavily to risk in that par-
ticular hospital’s common clinical groupings. It is desirable
to ﬁnd the comorbid conditions most relevant to risk of
deathforanyparticularillnessandusinganyrisk-adjustment
method. Also useful to individual hospitals would be a more
general list of those conditions that often contribute to local
mortality risk in a range of locally common illnesses.
2. Methods
2.1. Data Sources. We approached this problem using a
simple spreadsheet applied to our risk-adjusted data in two
diﬀerent risk adjustment methodologies, 3M (St. Paul, MN)
and University Healthcare Consortium (UHC, Chicago IL).
Downloads came from our decision support system
(McKesson HBOC, San Francisco, CA) for the 3M method
and from UHC. The Institutional Review Board approved
this approach and waived the requirement for individual
patient consent in analyzing this deidentiﬁed patient data.
2.2. Data Manipulations. Risk adjustment data from these
sources were downloaded onto separate Excel spreadsheets
(Microsoft, Redmond, WA). Spreadsheet manipulation was
divided into two phases: ﬁrst, counting the number of
instances of each comorbidity in each clinical grouping
(APRDRG for 3M or base MSDRG for UHC) and second,
identifying in each clinical grouping those comorbidities
whose prevalence increased markedly between contiguousComputational and Mathematical Methods in Medicine 3
Figure 1: Organization of the right side of the UHC risk level “above” spreadsheet to count occurrences of comorbidities in each of the 100
commonest base MSDRGs.
Figure 2: Slope of comorbidity prevalence among the commonest 100 base MSDRGs in all four levels of risk in the UHC methodology.
Comorbidities are shown in descending order of slope magnitude.
(and across all four) risk categories. These changes in
prevalence were measured as slopes (Figure 2).
Discharge level data was downloaded onto the left hand
side of eight spreadsheets, one for each of the four risk
adjustment levels in each risk adjustment methodology.
Separatecolumnscontainedforeachdischargethegroupings
APRDRG, MSDRG, and base MSDRG (UHC), and up to 50
coded comorbid conditions. Each sheet was sorted by the
grouping used in that risk adjustment methodology so that
discharges in the same grouping were in contiguous rows.
Counting comorbid conditions was achieved by creating
a grid on the right of each spreadsheet deﬁned by the
hundred commonest groupings (displayed along a row
as column headings) and (to the left of these displayed
in a column as row headings) all the comorbidities that
occurred once or more often. Cells at the junction of
a particular comorbidity row and a particular grouping
column were programmed to calculate the number of times
this comorbidity occurred in discharges belonging to that
grouping (within the level of risk to which the current
spreadsheet was assigned). This is shown in Figure 1.
In order to count comorbidities in these cells, a text
statement was developed for each cell that would, later, be
converted to a calculating formula. The text statement is
shown in Figure 1 (above the arrow) as it was written in
the formula bar for the highlighted cell. This statement was
assembled from concatenated fragments such as “=”a n d
“)” (also shown in Figure 1 below the formula bar), whose
spreadsheet location was speciﬁed in the formula bar text.
As the text statement was entered into each cell, adjusted
to reﬂect the particular row and column of that cell, the
cell processed “concatenate” commands and cell references
in the text, displaying the simpler statement shown in the
highlightedcellinFigure 1.Thissimpliﬁedstatement,copied
and “pasted as value,” was next converted to a formula in
all grouping columns by using the Excel command “replace”
to change “=”t o“ =”. This apparently purposeless maneuver
actually forces each cell to reexamine the text statement and
then treat it as a formula.
With the text statement changed to a formula, each cell
now directs that occurrences of the comorbidity named in
the current row be counted among the spreadsheet’s 50
columns devoted to comorbidities. However, this comorbid-
ity count is to be limited to the range of rows containing
patients in the grouping named by the current column.
For example, suppose in Figure 1 that the current cell in4 Computational and Mathematical Methods in Medicine
the “Above” risk level spreadsheet is the one highlighted
at the junction of MSDRG 88 (the grouping naming the
current column) and “V 8545 BMI > 69 adult” (the
comorbidity naming the current row). The highlighted cellis
instructing that all instances of “v8545” be counted in the 50
comorbiditycolumns(“s”through“bo”).However,counting
must occur only in the row range that contains discharges
in the “Above” risk level of MSDRG 88 (rows 8434 through
8545).
The ﬁrst of these rows was found in this clinical grouping
column(MSDRGinFigure 1)usingExcel’s“match”function
with the grouping name and risk level. Finding the last row
was achieved by adding to the “match” result the number of
rows containing that name (using the “countif” function).
In this manner, the number of occurrences of each
comorbidity among patients belonging to each grouping was
calculated in a matrix format. Occurrences in individual
groupings or across any number of groupings could then
readily be summed at each level of risk. Prevalence was
reported as the number of comorbidity occurrences divided
by the number of discharges, either in a single grouping or
across a range of groupings.
The second step in spreadsheet manipulation was to
evaluate changes in the prevalence of each comorbidity,
either within a particular grouping or across the commonest
groupings, as risk levels increase. This was achieved by
transferringthelistofcalculatedcomorbidityprevalencesfor
eachrisklevelintoanewspreadsheetanddeterminingrateof
change in these values (slope) for each comorbid condition
between risk levels from minor to extreme (APRDRG) or
well below to well above (UHC). Those morbidities with the
largest slopes were then identiﬁed by sorting (Figure 2).
3. Results
The 100 commonest groupings (accounting for about 90%
of discharges) were examined all together in both risk
adjustment methods, and the ten commonest (about 30%)
were examined from the perspective of individual grouping.
Shown in Table 1 are comorbidities with the largest 25
slopes across all risk levels for the 100 commonest groupings
in the two risk adjustment systems. The two methods shared
18 of the 25.
4. Discussion
Using this inductive method, we identiﬁed comorbid con-
ditions that were associated with increases in morbidity
risk category at a particular institution. It appears that the
method, applied here to two, could be used for many risk-
adjustment paradigms. Hospitals now focus on educating
doctors about the importance of documenting comorbid
conditions that increase the complexity and reimbursement
ofcommonDRGs.Perhapsequallyimportantinmaximizing
revenue and hospital reputation will be educating doctors
to identify and document those conditions that increase
risk of death. Risk may be measured by diﬀerent insurers
using diﬀerent methods, making an inductive approach to
Table 1: Comorbidities with the greatest slopes across all four risk
levels in the methods used by UHC and 3M.
Comorbidity 3M UHC
584.9: acute renal failure NOS ××
428.: CHF unspeciﬁed ××
518.81: acute respiratory failure ××
599.: urin tract INFEC/bacteriuria ××
V66.7: encounter for palliative care ××
486: pneumonia, organism NOS ××
57.: food/vomit pneumonitis ××
427.31: atrial ﬁbrillation ××
414.1: cornry atheroscelersis native ××
511.9: pleural eﬀusion NOS ××
276.1: Hyposmolality ××
518.: pulmonary collapse ××
276.2: acidosis ××
E849.7: ACCID in resident INSTIT ××
43.9: HY KID NOS W CR KID I-IV ××
198.5: secondary malig neo bone ××
285.9: anemia NOS ××
995.92: severe sepsis ××
25.: DMII WO COMP NT ST UNCNTR ×
785.52: septic shock ×
272.4: hyperlipidemia NEC/NOS ×
V15.82: history of tobacco use ×
77.3: decubitus ulcer, low back ×
41.9: hypertension ×
38.9: septicemia NOS ×
276.8: hypopotassemia ×
276.51: dehydration ×
244.9: hypothyroidism NOS ×
276.7: hyperpotassemia ×
585.9: chronic kidney dis NOS ×
287.5: thrombocytopenia NOS ×
197.7: secondary liver Ca ×
assessing the results of any method easier for a hospital than
trying to duplicate each method.
Animportantlimitationofthisapproachisthatitcannot
distinguish diagnoses deﬁning increased risk from those
associated with increased risk. The ﬁrst is clearly a subgroup
of the second, raising questions not about sensitivity but
the speciﬁcity of this method. An important topic for future
study is whether the likelihood increases with its slope
that a particular comorbidity places rather than accompanies
patients into a higher risk category.
Knowledge of comorbidities associated with risk has, of
course, the potential both to improve and to undermine
precision in risk adjustment. Just as it is likely for a hospital
to undercode comorbid conditions that it does not know
to be important, so the possibility of overcoding arises
when a hospital knows or suspects which diagnoses will
increase reported risk of death (and therefore improve its
observed/expected mortality). On the other hand, it can beComputational and Mathematical Methods in Medicine 5
argued that hospitals, which already suﬀer regulatory and
ﬁnancial consequences when they are found to overcode,
should not also, through ignorance of the basis for risk,
be systemically encouraged to underestimate their expected
mortality [20, 21]. In assessing the eﬀect of this or other
methods that may be developed to deconstruct risk adjust-
ment paradigms, it is important to measure the eﬀect both
on recognition and documentation of conditions that would
otherwise be missed and on reporting of conditions that are
not in fact present. As risk-adjusted mortality grows to be
more important a measure, these studies will hopefully be
performed.
Finally, it should be noted that widespread use of any
technique that accurately increases documentation and cod-
ing as a speciﬁc and rapid response to the results of risk ad-
justment may in turn aﬀect the process of risk adjustment
itself. For example, a comorbidity more widely reported be-
cause it is identiﬁed as enhancing risk will enhance risk less.
Shared knowledge of risks between adjusters and clinicians
may well create a dynamic relationship with unknown
eﬀects.
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